BridgeBio Pharma, Inc 10-Q for FY2023 Q2
BridgeBio Pharma, Inc. (BBIO)
10-Q
2023-08-03
For: 2023-06-30
View Original
Added on
April 08, 2026
About this 10-Q
BridgeBio Pharma, Inc filed this 10-Q on August 3, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).
Headline figures
Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $1.64M
- down 97.8% from $73.75M a year earlier
- Net loss
- $160.7M
- compared with a net loss of $2.56M a year earlier
- Diluted EPS
- -$0.98
- compared with -$0.07 a year earlier